Media stories about MAXIMUS (NYSE:MMS) have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MAXIMUS earned a news impact score of 0.21 on Accern’s scale. Accern also assigned news articles about the health services provider an impact score of 45.946285087292 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the media stories that may have impacted Accern Sentiment’s scoring:
- Insider Selling: MAXIMUS, Inc. (MMS) General Counsel Sells 3,600 Shares of Stock (americanbankingnews.com)
- MAXIMUS, Inc. to Post Q2 2018 Earnings of $0.85 Per Share, First Analysis Forecasts (MMS) (americanbankingnews.com)
- Jefferies Group Comments on MAXIMUS, Inc.’s Q2 2018 Earnings (MMS) (americanbankingnews.com)
- Research Analysts Offer Predictions for MAXIMUS, Inc.’s Q2 2018 Earnings (MMS) (americanbankingnews.com)
Shares of MAXIMUS (NYSE:MMS) traded up $0.72 during midday trading on Friday, hitting $67.26. The stock had a trading volume of 846,812 shares, compared to its average volume of 559,623. MAXIMUS has a 52 week low of $57.12 and a 52 week high of $72.71. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $4,380.00, a price-to-earnings ratio of 21.02, a price-to-earnings-growth ratio of 2.21 and a beta of 1.21.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be issued a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s payout ratio is 5.63%.
Several brokerages have recently weighed in on MMS. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a research report on Tuesday. Maxim Group reiterated a “hold” rating and set a $69.00 price target (up from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th. Finally, Canaccord Genuity reissued a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. MAXIMUS presently has an average rating of “Hold” and a consensus target price of $66.60.
In other news, insider Mark Andrekovich sold 5,594 shares of the business’s stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $67.23, for a total transaction of $376,084.62. Following the completion of the transaction, the insider now owns 27,996 shares of the company’s stock, valued at $1,882,171.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $69.25, for a total value of $2,077,500.00. The disclosure for this sale can be found here. Insiders have sold 68,244 shares of company stock valued at $4,699,326 in the last three months. 3.10% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This article was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://stocknewstimes.com/2018/02/18/maximus-mms-getting-somewhat-favorable-news-coverage-study-shows.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.